SYNERGISTIN INJECTABLE SUSPENSION DIN 00698083
Status: Cancelled Post Market
Holder: PFIZER CANADA INC ANIMAL HEALTH GROUP
Molecule: SULBACTAM (SULBACTAM BENZATHINE)
Health Canada record
| Active ingredient(s) | SULBACTAM (SULBACTAM BENZATHINE) 60 MG; AMPICILLIN 120 MG |
|---|---|
| Dosage form | Suspension |
| Route | Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1988 |
| Current status date | 28-Jul-2005 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 6591 | 1999-07-06 | New Drug Submission (NDS) |